Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer

Vijayalaxmi G. Gupta, Jeff Hirst, Shariska Petersen, Katherine F. Roby, Meghan Kusch, Helen Zhou, Makena L. Clive, Andrea Jewell, Harsh B. Pathak, Andrew K. Godwin, Andrew J. Wilson, Marta A. Crispens, Emily Cybulla, Alessandro Vindigni, Katherine C. Fuh, Dineo Khabele

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences